Galectin-3 and soluble RAGE as new biomarkers of post-infarction cardiac remodeling

被引:5
|
作者
Redondo, Alfredo [1 ,2 ]
Paradela-Dobarro, Beatriz [3 ,4 ]
Moscoso, Isabel [3 ,4 ]
Moure-Alvarez, Maria [1 ,2 ]
Cebro-Marquez, Maria [3 ]
Gonzalez-Juanatey, Jose Ramon [1 ,2 ,3 ,4 ]
Garcia-Seara, Javier [1 ,2 ,3 ,4 ]
Alvarez, Ezequiel [4 ,5 ]
机构
[1] Complexo Hosp Univ Santiago de Compostela CHUS, Serv Cardiol, SERGAS, Travesia Choupana S-N, Santiago De Compostela 15706, A Coruna, Spain
[2] Complexo Hosp Univ Santiago de Compostela CHUS, Unidad Hemodinam, SERGAS, Travesia Choupana S-N, Santiago De Compostela 15706, A Coruna, Spain
[3] Complexo Hosp Univ Santiago de Compostela CHUS, Unidad Hemodinam, Inst Invest Sanitaria Santiago de Compostela IDIS, Travesia Choupana S-N, Santiago De Compostela 15706, A Coruna, Spain
[4] CIBERCV, Madrid, Spain
[5] Complexo Hosp Univ Santiago de Compostela CHUS, Lab 6, Inst Invest Sanitaria Santiago de Compostela IDIS, SERGAS, Edif Consultas Externas,Planta 2, Santiago De Compostela 15706, A Coruna, Spain
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2021年 / 99卷 / 07期
关键词
Acute myocardial infarction with ST-segment elevation; Post-infarction remodeling; Galectin-3; Soluble RAGE; Biomarkers; GLYCATION END-PRODUCTS; MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; SERUM GALECTIN-3; HEART-FAILURE; RECEPTOR; FIBROSIS; EXPRESSION; S100B; ASSOCIATION;
D O I
10.1007/s00109-021-02054-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Post-infarction remodeling is a clinical problem with no curative treatment. Our objective was to search for new biomarkers of cardiac remodeling that have clinical value after ST-segment elevation myocardial infarction (STEMI). This pilot study enrolled 67 consecutive patients with de novo STEMI who underwent revascularization by primary angioplasty. Echocardiography studies of cardiac function were completed during the first 48 h post-STEMI and after 6 months of follow-up. Galectin-3 and soluble receptor for advanced glycation end products (sRAGE) were tested in the peripheral venous blood during the 24 h post-infarction. Cardiac remodeling was defined as changes >= 15% in the left ventricular end-systolic volume (LVESV) or > 10% in the left atrial area (LAA). An inverse association was found between galectin-3 (r(s) = - 0.296; p < 0.001) and sRAGE (r(s) = - 0.327; p < 0.001) levels and the basal left ventricle ejection fraction (LVEF). However, only galectin-3 was directly associated with the increase in LVESV (r(s) = 0.389; p = 0.007) and LVEDV (r(s) = 0.314; p = 0.031) during the follow-up. sRAGE was inversely related to the change in LAA (r(s) = - 0.320; p = 0.032). These data are consistent with galectin-3, but not sRAGE levels, as a predictor of left ventricle remodeling (OR 1.036, 95% CI 1.002-1.071; p = 0.039). Galectin-3 and sRAGE levels that were measured during hospitalization are inversely related to basal LVEF after a STEMI. Galectin-3 levels are a predictor of adverse post-STEMI LV remodeling, whereas sRAGE levels exhibited an inverse relationship with left atrial remodeling. Key messages Post-infarction remodeling is a clinical problem with no curative treatment. New biomarkers for remodeling after acute myocardial infarction were explored. Early post-STEMI galectin-3 and soluble RAGE are inversely related with left ventricle function. Galectin-3 levels were predictors of adverse post-STEMI left ventricle remodeling. Soluble RAGE levels were associated with left atrial remodeling.
引用
收藏
页码:943 / 953
页数:11
相关论文
共 50 条
  • [41] Biophysical and Lipidomic Biomarkers of Cardiac Remodeling Post-Myocardial Infarction in Humans
    Samouillan, Valerie
    Martinez de Lejarza Samper, Ignacio Miguel
    Benitez Amaro, Aleyda
    Vilades, David
    Dandurand, Jany
    Casas, Josefina
    Jorge, Esther
    de Gonzalo Calvo, David
    Gallardo, Alberto
    Lerma, Enrique
    Guerra, Jose Maria
    Carreras, Francesc
    Leta, Ruben
    Llorente Cortes, Vicenta
    BIOMOLECULES, 2020, 10 (11) : 1 - 20
  • [42] Apoptosis and post-infarction left ventricular remodeling
    Baldi, A
    Abbate, A
    Bussani, R
    Patti, G
    Melfi, R
    Angelini, A
    Dobrina, A
    Rossiello, R
    Silvestri, F
    Baldi, F
    Di Sciascio, G
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (02) : 165 - 174
  • [43] Non-fibrillar collagens: Key mediators of post-infarction cardiac remodeling?
    Shamhart, Patricia E.
    Meszaros, J. Gary
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2010, 48 (03) : 530 - 537
  • [44] RAGE/galectin-3 yields intraplaque calcification transformation via sortilin
    Sun, Zhen
    Wang, Zhongqun
    Li, Lihua
    Yan, Jinchuan
    Shao, Chen
    Bao, Zhengyang
    Jing, Lele
    Pang, Qiwen
    Geng, Yue
    Zhang, Lili
    ACTA DIABETOLOGICA, 2019, 56 (04) : 457 - 472
  • [45] Activation of Notch signaling in cardiomyocytes during post-infarction remodeling
    Oie, Erik
    Sandberg, Wiggo J.
    Ahmed, Mohammad Shakil
    Yndestad, Arne
    Laerum, Ole Didrik
    Attramadal, Havard
    Aukrust, Pal
    Eiken, Hans Geir
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2010, 44 (06) : 359 - 366
  • [46] Galectin-3: A potential new target for upstream therapy of atrial fibrillation
    He, Bo
    Huang, Bing
    Lu, Zhibing
    He, Wenbo
    Jiang, Hong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 203 : 1131 - 1132
  • [47] Circulating Galectin-3 Evaluation in Dogs With Cardiac and Non-cardiac Diseases
    Lee, Ga-Won
    Kang, Min-Hee
    Ro, Woong-Bin
    Song, Doo-Won
    Park, Hee-Myung
    FRONTIERS IN VETERINARY SCIENCE, 2021, 8
  • [48] Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure
    Lala, R. I.
    Lungeanu, D.
    Darabantiu, D.
    Pilat, L.
    Puschita, M.
    HERZ, 2018, 43 (02) : 146 - 155
  • [49] Identification of key proteins as potential biomarkers associated with post-infarction complications in diabetics
    Wu, Wei
    Yan, Li
    Yuan, Xiao-Fei
    Wang, Lu
    Zhang, Yu
    Tu, Rong-xiang
    Pan, Jiang-Qi
    Yin, Lu
    Ge, Zhi-Ru
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2023, 37
  • [50] Temporal expression of galectin-3 following myocardial infarction
    Milner, Thomas D.
    Viner, Alexandra C.
    MacKinnon, Alison C.
    Sethi, Tariq
    Flapan, Andrew D.
    ACTA CARDIOLOGICA, 2014, 69 (06) : 595 - 602